1. Zhao N, Chen QG, Chen X, Liu XT, Geng F, Zhu MM, Yan FL,Zhang ZJ, Ren QG*. Intestinal dysbiosis mediates cognitive impairment via the intestine and brain NLRP3 inflammasome activation in chronic sleep deprivation.Brain Behav Immun.2023; 108:98-117（2021 IF=19.227）

2. Kong Y Y *, Niu S, Gao H, Yue YY, Shu H, Xie CM,Zhang ZJ, Yuan YG*. Multi-Stage Graph Fusion Networks for Major Depressive Disorder Diagnosis.IEEE T Affect Comput. 2022; 13(4):1917-1928（2021 IF=13.99）

3. Yang HB, Yu ZY, Ji SS, Yan J, Kong Y, Huo Q,Zhang ZJ*, Niu YM*, and Liu Y*. Regulation of synovial macrophages polarization by mimicking efferocytosis for therapy of osteoarthritis.Adv Funct Mater.2022 Accepted.（2021 IF=19.924）

4. Dang XL,Zhang ZJ*, Luo XJ*. Mendelian randomization using dopaminergic neuron eQTL identifies risk genes for Parkinson's disease.Movement Disord. 2022 Accepted.（2021 IF=9.698）

5. Wang JY, Liu JW, Li SW, Li XY, Yang JF, Dang XL, Mu CG, Li YF, Li KQ, Li J, Chen R, Liu YX, Huang D,Zhang ZJ, Luo XJ*. Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus.Brain. 2022 Accepted. （2021 IF=15.255）

6. Chen R, Yang ZH, Liu JW, Cai X, Huo YX,Zhang ZJ, Li M*, Chang H* and Luo XJ*. Functional genomic analysis delineates regulatory mechanisms of GWAS‑identified bipolar disorder risk variants.Genome Med. 2022; 14(1):53 （2021 IF=15.266）

7. Han YH, Wu D, Wang YJ, Xie J,Zhang ZJ*. Skin alph a-synuclein deposit patterns: A predictor of Parkinson's disease subtypes.EBioMedicine. 2022; 80: 104076 （2021 IF= 11.205）

8. Xie J#, Cheng ZH#, Gu LH, Wu BK, Zhang GJ, Shiu WS, Chen RL, Wang Z, Liu C, Tu J, Cai XC, Liu J*,Zhang ZJ*. Evaluation of cerebrovascular hemodynamics invascular dementia patients with a new individual computational fluid dynamics algorithm.Comput Meth Prog Bio. 2022; 213:106497（2021 IF= 7.027）

9. Lu QB#, Wu FF#, Jiao J, Xue L, Song RZ, Shi YC, Kong Y, Sun JF, Gu N, Han MH*, Zhang ZJ*. Selective activation of ABCA1/ApoA1 signalling in the primary visual cortex by magnetoelectric stimulation rapidly ameliorates depression-like behaviours via regulation of synaptic plasticity.iScience. 2022; 25(5):104201 （2021 IF=6.107）

10. Jiao J, Wang F*, Huang JJ, Huang JJ, Li ZA, Kong Y,Zhang ZJ*.Microfluidic Hollow Fiber with Improved Stiffness Repairs Peripheral Nerve Injury through Non-invasive Electromagnetic Induction and Controlled Release of NGF.Chem Eng J. 2021; 426 :131826（2021 IF=16.744）

11. Shi YC#, Song RZ#, Wang Z#, Zhang H, Zhu JL, Yue YY, Zhao Y*,Zhang ZJ*. Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder.EBioMedicine. 2021;66:103337（2021 IF = 11.205）

12. Shi YC#, Song RZ#, Wang Z#, Zhang HX, Zhu JL, Yue YP, Zhao Y*, andZhang ZJ*. Non-coding RNAs in depression: promising diagnostic and therapeutic biomarkers.EBioMedicine. 2021;71:103569（2021 IF = 11.205）

13. Gao LJ, Gu LH, Shu H, Chen J, Zhu JL, Wang B, Shi YC, Song RZ, Li K, Li XR, Zhang HS, Zhang HX,Zhang ZJ*. The reduced left hippocampal volume related to the delayed P300 latency in amnestic mild cognitive impairment.Psychol Med. 2021; 51(12):2054-2062（2021 IF= 10.592）

14.Zhang ZJ#*, Zhang HX#, Xie CM#, Zhang M#, Shi YH, Song RZ, Lu X, Zhang HS, Li K, Wang B, Yang YF, Li XR, Zhu JL, Zhao Y, Yuan TF and Northoff Georg*. Task-related functional magnetic resonance imaging-based neuronavigation for the treatment of depression by individualized repetitive transcranial magnetic stimulation of visual cortex.Sci China Life Sci. 2021; 64 (1) :96-106（2021 IF=10.372）

15. Zuo L, Xie J, Liu Y, Leng S,Zhang ZJ*, Yan FL*. Down-regulation of circular RNA CDC14A peripherally ameliorates brain injury in acute phase of ischemic stroke.J Neuroinflamm.2021; 18:283（2021 IF= 9.587）

16. Qian FY, Guo YD, Zu J, Zhang JH, Zheng YM, Ali AI, Pan ZH, Xie CM*, Gao HC*, Zhang ZJ*. A novel recessive mutation affecting DNAJB6a causes myofibrillar myopathy.Acta Neuropathol Com. 2021; 9(1) :23（2021 IF=7.578）

17. Shu H#, Gu LH#, Yang P#, Lucas MV, Gao LJ, Zhang H, Zhang H, Xu Z, Wu W*, Li L*, Zhang ZJ*. Disturbed temporal dynamics of episodic retrieval activity with preserved spatial activity pattern in amnestic mild cognitive impairment: A simultaneous EEG-fMRI study.NeuroImage-Clin. 2021; 30 :102572（2021 IF=7.4）

18. Shi YC#, Wang Z#, Cheng PD, Cheng PY, Zhao K, Zhang HX, Shu H, Gu LH, Wang Q, Zhang HS, Xie CM, Liu Y*, andZhang ZJ*. Episodic memory-related imaging features as valuable biomarkers for the diagnosis of Alzheimer’s disease: A multicenter study based on machine learning.Biol Psychiat-Cogn N. 2021; 20 :30378-30385（2021 IF=6.05）

19. Zhang Y#, Du LF#, Bai Y#, Han B#, He CC#, Gong L, Huang RR, Shen L, Chao J, Liu P, Zhang HX, Zhang HS, Gu L, Li JX, Hu G, Xie CM*,Zhang ZJ*, Yao HH*. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination.Mol Psychiatr. 2020; 25(6):1175–1190. （2021 IF=13.437）

20. Zuo L, Zhang L, Zu J, Wang Z, Han B, Chen BL, Cheng MJ, Ju MZ, Li MY, Shu GF, Yuan MQ, Jiang W, Chen XF, Yan FL,Zhang ZJ*and Yao HH*. Circulating circular RNAs as biomarkers for the diagnosis and prediction of outcomes in acute ischemic stroke.Stroke. 2020; 51(1):319–323（2021 IF=10.17）

21. Xu Z, Xie CM, Xia L, Yuan YG, Zhu H, Huang XF, Li CH, Tao Y, Qu XX, Zhang FY*, Zhang ZJ*. Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder.Transl Psychiat. 2020; 10(1):30（2021 IF= 7.989）

22. Lu QB#, Sun JF#, Yang QY, Cai WW, Xia MQ, Wu FF, Gu N*,Zhang ZJ*. Brain magnetic stimulation using iron oxide nanoparticle-mediated selectivetreatment of the left prelimbic cortex as a novel strategy to rapidly improve depressive-like symptoms in mice.Zool Res. 2020; 41(4):381–394（2021 IF=6.975）

23. Zhang Y, Huang RR, Cheng MJ, Wang LR, Chao J, Li JX, Zheng P, Xie P,Zhang ZJ, Yao HH*. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2.Microbiome. 2019; 7(1):116（2021 IF=16.837）

24. Liao WX, Zhang XR*, Shu H, Wang Z, Liu D,Zhang ZJ*. The characteristic of cognitive dysfunction in remitted geriatric depression and amnestic mild cognitive impairment.Psychiat Res. 2017; 251:168-175（2021 IF=11.225）

25. Bai F*, Shi YM, Yuan YG, Xie CM,Zhang ZJ*. Immunity factor contributes to altered brain functional networks in individuals at risk for Alzheimer’s disease: Neuroimaging-genetic evidence.Brain Behav Immun. 2016;56:84-95（2021 IF=19.227）

26. Shu H#, Shi YM#, Chen G, Wang Z, Liu D, Yue CX, Ward D, Li W, Xu Z, Chen G, Guo Q, Xu J, Li SJ*,Zhang ZJ*. Opposite neural trajectories of apolipoprotein E I mu 4 and I mu 2 alleles with aging associated with different risks of Alzheimer's disease.Cereb Cortex. 2016, 26(4):1421–1429（2021 IF=4.861）

27. Xie C*, Bai F, Yuan BY, Yu H, Shi YM, Yuan YG, Wu D, Zhang ZS,Zhang ZJ*. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.Psychol Med2015; 45(9):1799-1810（2021 IF=10.592）

28. Deng M, Wei L, Zuo XB, Tian YH, Xie F, Hu PP, Zhu CY, Yu FQ, Meng Y, Wang HH, Zhang FF, Ma HJ, Ye R, Cheng HD, Du J, Dong WW, Zhou SS, Wang CQ, Wang Y, Wang JY, Chen XW, Sun ZW, Zhou N, Jiang YB, Liu XX, Li XG, Zhang N, Liu N, Guan YJ, Han YS, Han YZ, Lv XY, Fu Y, Yu H, Xi CH, Xie DD, Zhao QY, Xie P, Wang X, Zhang ZJ, Shen L, Cui Y, Yin XY, Cheng H, Liang B, Zheng XD, Tatia M C Lee, Chen G, Zhou FS, Jan H Veldink, Wim Robberecht, John E Landers, Peter M Andersen, Ammar Al-Chalabi, Chris Shaw, Liu CF, Tang BS, Xiao SX, Janice Robertson, Zhang FY, Leonard H van den Berg, Sun LD, Liu JJ, Yang S, Ju XD, Wang K*& Zhang XJ. Genome-wide association analyses in Han Chinese identify two newsusceptibility loci for amyotrophic lateral sclerosis. Nat Genet.2013;

45(6):697-702.（2021 IF=41.307） 29. Zhang XY, Liu L, Liu S, Hong X, Chen da C, Xiu MH, Yang FD,Zhang ZJ, Zhang X, Kosten TA, Kosten TR. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.Am J Psychiat. 2012;169(9):974-81 （2021 IF=19.242）

30. Zhuang LY, Kiu XY, Xu XH, Yue CX, Shu H, Bai F, Yu H, Shi YM,Zhang ZJ*. Association of the interleukin 1 beta gene and brain spontaneous activity in amnestic mild cognitive Impairment.J Neuroinflamm. 2012;9:753（2021 IF=9.587）

31. Xie CM, Bai F, Yu H, Shi YM, Yuan YG, Chen G, Li WJ, Chen GY,Zhang ZJ*, Li SJ*. Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment.NeuroImage.2012; 63(1): 320-327（2021 IF=7.4）

32. Bai F#, Shu N#, Yuan Y, Shi Y, Yu H, Wu D, He Y*,Zhang ZJ*. Topologically convergent and divergent connectivity patterns of white matter structural networks between remitted geriatric depression and mild cognitive impairment. J Neurosci. 2012; 32(12): 4307–4318（2021 IF=6.709）

33. Xie CM, Joseph Goveas, Wu ZL, Li WJ, Chen GY, Malgorzata Franczak, Piero G. Antuono, Jennifer L. Jones,Zhang ZJ*,Li SJ*. Neural basis of the association between depressive symptoms and memory deficits in nondemented subjects: resting-state fMRI study.Hum Brain Mapp.2012;33(6):1352-63（2021 IF=5.399）

34. Zhang HY, Wang SJ, Liu B, Ma ZL, Yang M,Zhang ZJ, Teng GJ. Resting brain connectivity: changes during the progress of Alzheimer disease.Radiology.2010; 256(2): 598-606（2021 IF=29.146）

35. Bai F,Zhang ZJ*, David R. Watson, Hui Yu, Shi YM, Yuan YG, Zang YF, Zhu CZ, Qian Y. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment.Biol Psychiat.2009; 65(11): 951-958（2021 IF=12.81）

36. Wang SH,Zhang ZJ*, Guo YJ, Teng GJ, Chen BA.Decreased expression ofserotonin 1A receptor in the dentate gyrus in association with chronic mild stress: A rat model of post-stroke depression. Psychiat Res.2009; 170 (2-3): 245-251（2021 IF=11.225）

37. Zhang XB,Zhang ZJ*, Sha WW, Xie CM, Xi GJ, Zhou HH, Zhang YM. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression.Psychiat Res. 2009; 170 (2-3): 273-275（2021 IF=11.225）

38. Yuan YG, Zhu WL,Zhang ZJ*, Bai F, Yu H, Shi YM, Qian Y , Liu W, Jiang TZ, You JY, Liu ZN. Regional gray matter changes are associated with cognitive deficits in remitted geriatric depression: an optimized voxel-based morphometry study. Biol Psychiat.2008; 64 (6): 541-544（2021 IF=12.81）

39.Zhang ZJ*, Hao GF, Shi JB, Mou XD, Yao ZJ, Chen N. Investigation of the neural substrates of voice familiarity in Chinese schizophrenic patients with auditory verbal hallucination：A event-related fMRI study.Acta Psychiat Scand. 2008;118(4): 272-280.（2021 IF=7.734）

40. Wang CJ,Zhang ZJ*,Sun J, Zhang XB, Mou XD, Zhang XR, Shang XF, Zhang TQ.Serum free fatty acids and glucose metabolism , insulin resistance in schizophrenia with chronic antipsychotics. Biol Psychiat.2006; 60(12): 1309-1313（2021 IF=12.81）

41.Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP.Effects of antipsychotics on fat deposition and changes in leptin and insulin levels-Magnetic imaging study of previously untreated people with schizophrenia. Brit J Psychiat.2004; 184: 58-62 （2021 IF=10.671）

42. Reynolds GP,Zhang ZJ,Zhang XB.Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet.2002; 359 (9323): 2086-2087 （2021 IF=202.731）

43.Zhang ZJ, Zhang XB, Sha WW, Zhang XB, Reynolds GP.Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia. Mol Psychiatr.2002; 7(7):670-671（2021 IF=13.437）

44. Bearsly CL,Zhang ZJ, Patten I, Reynolds GP.Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiat.2002; 52(7): 708-715（2021 IF=12.81）

45.Zhang ZJ, Reynolds GP.A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res.2002; 55(1-2):1-10.